Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

NCT00841399 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

FED

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: E75 + GM-CSF vaccine

Sponsor

COL George Peoples, MD, FACS

Collaborators

[object Object]